Drugs Channel
Topics & Medications
Quicklinks
Related Channels

Ruxolitinib Drug Information

Ruxolitinib (JakafiTM) is a medication licensed for the treatment of a rare bone marrow disease called myelofibrosis. This prescription medicine is approved for use in adults only, and works by preventing the formation of abnormal blood cells. It comes in tablet form and is typically taken twice daily.
 
Most people who use ruxolitinib will develop some type of side effect, such as dizziness, headaches, or bruising. In some cases, reactions to this drug can be significant and may require medical treatment.
 
Before using ruxolitinib, make sure your healthcare provider has up-to-date information on any other drugs you are taking (including vitamins and supplements), as well as any allergies you may have, including to medications, foods, dyes, or preservatives. Also, let your healthcare provider know if you are pregnant or breastfeeding.
 
(For more information on this drug, click Ruxolitinib. This Web selection provides more details on how this medicine works, dosing guidelines, and general safety precautions to be aware of before beginning treatment.)
 

Ruxolitinib Drug Information

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2018 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.